Reported Reactions

Devices › Implant, dermal, for aesthetic use

Device brand name · Implant dermal for aesthetic use

Juvederm VOLUMA WITH LIDOCAINE 1mL: medical device reports filed with FDA

622 reports name it, 2014–2026. Manufacturer given most often on reports: Allergan Pringy. Product code LMH.

622
device reports naming the brand
0% of all MAUDE reports · about 50 a year
23
reports, 12 months to August 2026
14 in the 12 months before
16.6%
classified as malfunction
7.2% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 622 reports that name the brand "Juvederm VOLUMA WITH LIDOCAINE 1mL" (implant dermal for aesthetic use), received between January 2014 and August 2026; the manufacturer given most often on reports is Allergan Pringy. Spellings of one product vary from report to report.

23 reports arrived in the 12 months to August 2026, up 64% from 14 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (83.4%) and malfunction (16.6%); across all implant, dermal, for aesthetic use reports (product code LMH) death is recorded in 0.1% and malfunction in 7.2%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are improper or incorrect procedure or method (5.3%), expulsion (4.5%) and detachment of device component (4.2%). The patient problems coded most often are skin irritation, edema and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

036Sep 2021: 4Oct 2021: 5Nov 2021: 3Dec 2021: 22022Jan 2022: 2Feb 2022: 1Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 3Jul 2022: 0Aug 2022: 4Sep 2022: 4Oct 2022: 2Nov 2022: 3Dec 2022: 12023Jan 2023: 0Feb 2023: 3Mar 2023: 4Apr 2023: 1May 2023: 3Jun 2023: 6Jul 2023: 1Aug 2023: 2Sep 2023: 4Oct 2023: 1Nov 2023: 2Dec 2023: 02024Jan 2024: 0Feb 2024: 4Mar 2024: 1Apr 2024: 0May 2024: 1Jun 2024: 0Jul 2024: 0Aug 2024: 2Sep 2024: 2Oct 2024: 2Nov 2024: 0Dec 2024: 02025Jan 2025: 2Feb 2025: 2Mar 2025: 0Apr 2025: 2May 2025: 1Jun 2025: 1Jul 2025: 1Aug 2025: 1Sep 2025: 1Oct 2025: 4Nov 2025: 2Dec 2025: 12026Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 4May 2026: 0Jun 2026: 6Jul 2026: 0Aug 2026: 3

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0591172014: 4820142015: 432016: 5220162017: 922018: 11720182019: 822020: 5920202021: 372022: 2020222023: 272024: 1220242025: 182026: 152026

Event type and report source

Event type, as classified on the report

Death0%0
Injury83.4%519
Malfunction16.6%103
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%622
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 22,802 reports carrying product code LMH. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Improper or incorrect procedure or method335.3%7.5%
Expulsion284.5%1%
Detachment of device component264.2%1.7%
Crackthe device cracked223.5%0.9%
Gel leak213.4%1.3%
Detachment of device or device componentpart of the device came off193.1%1.9%
Breakthe device broke172.7%0.9%
Burst container or vessel121.9%0.3%
Off-label use91.4%4.2%
Leak/splashthe device leaked40.6%1%
Migrationthe device moved from where it was placed40.6%0.4%
Patient-device incompatibilitythe device did not suit the patient30.5%2.4%
Connection problema connection problem20.3%0%
Defective component20.3%0.1%
Fitting problem20.3%0%
Fracturea broken bone20.3%0%
Migration or expulsion of device20.3%0.7%
Activation, positioning or separation problem10.2%0%
Bent10.2%0%
Biofilm coating in device10.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Skin irritationirritated skin22035.4%
Edemaswelling from fluid15925.6%
Inflammationinflammation14823.8%
Painpain, site not specified7411.9%
Erythemaskin redness569%
Abscessa collection of pus548.7%
Nodule294.7%
Hypersensitivity/allergic reaction264.2%
Skin discoloration254%
Vascular system (circulation), impaired233.7%
Obstruction/occlusion162.6%
Granuloma152.4%
Necrosisdeath of tissue121.9%
Ischemia111.8%
Cellulitisa skin infection101.6%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureJuvederm VOLUMA WITH LIDOCAINE 1mLProduct code LMHAll MAUDE reports
Reports62222,80226,136,888
Share of that pool—2.7%0%
Classified as death, per 1,000 reports019
Classified as injury83.4%83.7%36.2%
Classified as malfunction16.6%7.2%62.3%
Filed by the manufacturer100%95.3%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code LMH

BrandReportsLatest 12 monthsClassified as death
Sculptra1,593910%
Juvederm Voluma Xc/Lido Volume Unknown1,0471940.1%
Juvederm Voluma XC 27G 2 x 1mL901780%
Juvederm Ultra Xc Tsk Us68110%
Unk Volbella663700%
VOLBELLA with LIDOCAINE64150.2%
Radiesse Dermal Filler59600%
Juvederm Volume/Concentration/Additive Unknown502240.6%
Juvederm Ultra Plus Xc Tsk Us49550%
Zyplast Collagen Implant46600%
VOLIFT with LIDOCAINE458100%
Unk Juvederm Volux4451330%
Radiesse Injectable Implant44100%
JUVEDERM VOLLURE XC 2x1 mL427240.5%
Juvederm Voluma Volume/Additive Unknown426130%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Juvederm VOLUMA WITH LIDOCAINE 1mL reports

How many FDA reports name Juvederm VOLUMA WITH LIDOCAINE 1mL?

622 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 23 in the latest 12 months.

What kinds of events are reported?

injury (83.4%) and malfunction (16.6%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

improper or incorrect procedure or method (5.3%), expulsion (4.5%), detachment of device component (4.2%), crack (3.5%) and gel leak (3.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Juvederm VOLUMA WITH LIDOCAINE 1mL was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.